BioLargo, Inc.

10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Regulation FD disclosure May 6, 2026 8-K Regulation FD disclosure May 4, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Entered a material agreement; Unregistered sale of equity Mar 25, 2026 8-K Regulation FD disclosure Mar 5, 2026 10-K Fiscal year ended 2025-12-31 Mar 4, 2026 8-K Other events Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Regulation FD disclosure Nov 14, 2025 8-K Regulation FD disclosure Oct 20, 2025 8-K Terminated a material agreement; Material impairment; Regulation FD disclosure Sep 25, 2025 8-K Regulation FD disclosure Aug 15, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Regulation FD disclosure Jul 23, 2025 8-K Shareholder vote results Jun 25, 2025 8-K Regulation FD disclosure May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Regulation FD disclosure Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Regulation FD disclosure Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Regulation FD disclosure Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Shareholder vote results Jun 20, 2024 8-K Regulation FD disclosure Jun 13, 2024 8-K Regulation FD disclosure May 15, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Regulation FD disclosure Jan 22, 2024 8-K Regulation FD disclosure Jan 10, 2024 8-K Changed accountants Jan 5, 2024 8-K Regulation FD disclosure Nov 21, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Regulation FD disclosure Oct 4, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Shareholder vote results Jun 12, 2023 8-K Regulation FD disclosure Jun 9, 2023 8-K Regulation FD disclosure Jun 6, 2023 8-K Regulation FD disclosure May 18, 2023